Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-19 Purchase |
2022-05-23 4:54 pm |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
3,948 | $0.644 | $2,543 | 48,091 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Option Award |
2023-03-03 5:00 pm |
N/A 2023-03-01 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Cheif Financial Officer |
90,000 | $0 | 138,091 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-21 4:05 pm |
N/A 2029-03-07 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
62,500 | $0 | 106,643 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-09 8:22 pm |
N/A 2029-03-07 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Cheif Financial Officer |
62,500 | $0 | 106,643 (Direct) |
View |
| 2020-12-28 Conversion |
2020-12-29 9:52 pm |
N/A N/A |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
44,143 | $10 | 144,143 (Indirect) |
View |
| 2020-12-22 Option Award |
2020-12-29 9:52 pm |
N/A 2030-12-22 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
100,000 | $0 | 144,143 (Direct) |
View |
| 2020-12-28 Conversion |
2020-12-29 9:52 pm |
2020-12-28 2021-12-31 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
441,432 | $0 | 144,143 (Indirect) |
View |
Ownership |
2020-12-22 8:42 pm |
2020-08-25 2027-08-25 |
Inhibikase Therapeutics Inc. | IKT | FRATTAROLI JOSEPH Chief Financial Officer |
0 | $0 | 171,854 (Indirect) |
View |